Sertraline (Serlife)
Sertraline
Ranbaxy (SA) (Pty) Ltd
Registration
- Applicant
- Ranbaxy (SA) (Pty) Ltd
- Certificate holder
- Ranbaxy Pharmaceuticals {Pty) Ltd
- Registrations
- 2
- Schedule source
- SAHPRA documentation
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Serlife 50 EACH TABLET CONTAINS SERTRALINE HYDROCHLORIDE EQUIVALENT TO SERTRALINE 50,0 mg | 50Each film coated tablet | 36027236/1.2/0272Approved 4 November 2022 | Registered | S5 | PIPIL |
| Serlife 100 EACH TABLET CONTAINS SERTRALINE HYDROCHLORIDE EQUIVALENT TO SERTRALINE 100,0 mg | 100Each film coated tablet | 36027336/1.2/0273Approved 4 November 2022 | Registered | S5 | PIPIL |
Regulatory status
Where S5 sits on the scale
Prescription-only, with tighter controls on repeats.
Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S5, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Sertraline hydrochloride equivalent to sertraline
S5: Sertraline
Consolidated Schedules 06 July 2026, line 9691
Pharmacological class: Psychoanaleptics (antidepressants). (class 1.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(1S,4S)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
Drag to rotate. Structure from PubChem CID 68617.
SAHPRA documents
Schedule Verification
This medication's schedule (S5) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.